Control Sterol and Lipoprotein Homeostasis by miRNA
通过 miRNA 控制甾醇和脂蛋白稳态
基本信息
- 批准号:9106554
- 负责人:
- 金额:$ 39.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-05-01 至 2020-02-29
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAnimalsAntisense OligonucleotidesAortaArterial Fatty StreakBasic ScienceBile fluidBiochemicalBolus InfusionCandidate Disease GeneCardiovascular DiseasesCardiovascular systemCellular biologyCholesterolCholesterol HomeostasisClinicalDataDependovirusDiabetes MellitusDietDiseaseFatty LiverFibrosisFundingGene SilencingGenesGluconeogenesisGoalsHepaticHepatocyteHigh Density LipoproteinsHigh Fat DietHigh PrevalenceHomeostasisHumanHyperglycemiaHyperinsulinismHyperlipidemiaIncidenceIndividualInflammationInjection of therapeutic agentInsulinInsulin ResistanceInterventionIntronsKnowledgeLabelLaboratoriesLeadLinkLipidsLipoproteinsLiverLiver diseasesLow Density Lipoprotein ReceptorLow-Density LipoproteinsMediatingMediator of activation proteinMedicalMessenger RNAMetabolic ControlMetabolismMicroRNAsModelingMolecularMusObese MiceOligonucleotidesPathway interactionsPatientsPeripheralPharmaceutical PreparationsPhysiologicalPlant RootsPlasmaPopulationPreparationPublic HealthRNA-Induced Silencing ComplexRoleSRE-2 binding proteinSafetySpecificitySterolsStimulusTCF7L2 geneTechniquesTestingTherapeuticTimeTissuesUp-RegulationVery low density lipoproteinatherogenesisbaseblood glucose regulationcardiovascular risk factordiabetes riskdiabetogenicglucose productionglycemic controlhuman diseasehumanized mouseimprovedin vivoinsightinsulin sensitivityinterestlipid metabolismmouse modelnoveloverexpressionpleiotropismpublic health relevanceresearch studyresponsereverse cholesterol transport
项目摘要
DESCRIPTION (provided by applicant): Deregulation of lipid metabolism is the basis of some of the most common medical disorders in western populations, such as cardiovascular disease, fatty liver diseases, hyperlipidemia, and diabetes. The long-term goal in our laboratory is to gain
a better understanding of whole-body lipid homeostasis in response to physiological, pathological, and pharmacological stimuli. In the previous cycle, we studied the role of the statin-induced murine miR-33 on hepatic lipid metabolism, HDL and bile secretion, reverse cholesterol transport, and atherogenesis. The current proposal includes two large sets of studies: first, to continue our studies on miR-33; and second, to introduce additional statin-induced miRNAs and study their role on hepatic metabolic control. In the first half of this proposal, we will use a novel liver-humanized mouse to continue our currently funded studies on miR-33. These mice overcome the critical limitations of traditional murine models, restoring hepatic human miR-33a and miR-33b, human miR-33 target specificity, and human-like lipoprotein profiles. The proposed studies will provide critical data on the consequences of therapeutic silencing of miR-33 in a human, functional liver. On the other hand, we present evidence that statins induce changes in the murine hepatic RISCome (RNA-induced silencing complex-associated mRNAs) in vivo. Among these changes, we focus on the miR-183/96/182 cluster target TCF7L2, and present evidence that the SREBP2-miR-183/96/182-TCF7L2 pathway mediates statin-stimulated hepatic glucose production in vivo. The translational relevance of this new conserved pathway is enhanced by the recently described diabetogenic effect of statins. We will test these new ideas using a combination of biochemical, cell biology, and in vivo techniques. Specifically, Aim 1 will test the functional role of human hepatic miR-33a and miR-33b on hepatic lipid metabolism, lipoprotein secretion, and atherogenesis. Importantly, the unique liver-humanized mice will also allow us to test for the first time the contribution of miR-33b to diet-induced fatty liver and hepatic insulin resistance. Aim 2 will define the functiona role of miR-183/96/182 on hepatic and whole-body glucose homeostasis, by determining the contribution of each miR to hepatic glucose production, defining the mechanism by which the miR cluster and TCF7L2 regulate gluconeogenesis, and studying whether the levels of miR-183/96/182 and their functional targets are altered in murine models of altered glycemic control. The insights from these studies will fill a current gap of knowledge in pathophysiological hepatic metabolic control, and may uncover novel pharmacological targets to manage liver diseases, diabetes, and cardiovascular risk.
描述(由申请人提供):脂质代谢失调是西方人群中一些最常见医学疾病的基础,如心血管疾病、脂肪肝疾病、高脂血症和糖尿病。我们实验室的长期目标是
更好地了解全身脂质稳态对生理,病理和药理刺激的反应。在前一个周期中,我们研究了他汀类药物诱导的小鼠miR-33对肝脏脂质代谢、HDL和胆汁分泌、胆固醇逆向转运和动脉粥样硬化形成的作用。目前的建议包括两大组研究:第一,继续我们对miR-33的研究;第二,引入其他他汀类药物诱导的miRNA并研究它们在肝脏代谢控制中的作用。在本提案的前半部分,我们将使用一种新的肝脏人源化小鼠继续我们目前资助的miR-33研究。这些小鼠克服了传统小鼠模型的关键限制,恢复了肝脏人类miR-33 a和miR-33 b、人类miR-33靶特异性和人类样脂蛋白谱。拟议的研究将提供有关miR-33在人类功能性肝脏中治疗性沉默的后果的关键数据。另一方面,我们提出的证据表明,他汀类药物在体内诱导小鼠肝脏RISCome(RNA诱导的沉默复合物相关的mRNA)的变化。在这些变化中,我们重点关注miR-183/96/182簇靶点TCF 7 L2,并提供证据表明SREBP 2-miR-183/96/182-TCF 7 L2通路介导体内他汀类药物刺激的肝脏葡萄糖产生。最近描述的他汀类药物的致糖尿病作用增强了这种新的保守途径的翻译相关性。我们将结合生物化学、细胞生物学和体内技术来测试这些新想法。具体而言,目标1将测试人肝脏miR-33 a和miR-33 b对肝脏脂质代谢、脂蛋白分泌和动脉粥样硬化形成的功能作用。重要的是,独特的肝脏人源化小鼠也将使我们能够首次测试miR-33 b对饮食诱导的脂肪肝和肝脏胰岛素抵抗的贡献。目的2将确定miR-183/96/182对肝脏和全身葡萄糖稳态的功能作用,通过确定每个miR对肝脏葡萄糖产生的贡献,确定miR簇和TCF 7 L2调节肝脏生成的机制,并研究miR-183/96/182及其功能靶标的水平是否在血糖控制改变的小鼠模型中改变。这些研究的见解将填补目前在病理生理学肝脏代谢控制方面的知识空白,并可能发现新的药理学靶点来管理肝脏疾病,糖尿病和心血管风险。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Angel Baldan其他文献
Angel Baldan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Angel Baldan', 18)}}的其他基金
Role of cytosolic DNA-induced sterile inflammation driving cellular and organismal progeria/aging hallmarks
细胞质 DNA 诱导的无菌炎症在驱动细胞和机体早衰/衰老标志中的作用
- 批准号:
10901042 - 财政年份:2023
- 资助金额:
$ 39.01万 - 项目类别:
Role of self-DNA and sterile inflammation driving age/progeria-related metabolic defects
自身 DNA 和无菌炎症驱动年龄/早衰相关代谢缺陷的作用
- 批准号:
10688319 - 财政年份:2022
- 资助金额:
$ 39.01万 - 项目类别:
The role of FSP27b on dietary lipid absorption, lipoprotein secretion, and oxidative metabolism
FSP27b 对膳食脂质吸收、脂蛋白分泌和氧化代谢的作用
- 批准号:
10337294 - 财政年份:2020
- 资助金额:
$ 39.01万 - 项目类别:
The role of FSP27b on dietary lipid absorption, lipoprotein secretion, and oxidative metabolism
FSP27b 对膳食脂质吸收、脂蛋白分泌和氧化代谢的作用
- 批准号:
10552559 - 财政年份:2020
- 资助金额:
$ 39.01万 - 项目类别:
Control of Sterol and Lipoprotein Homeostasis by miRNA
miRNA 对甾醇和脂蛋白稳态的控制
- 批准号:
8254375 - 财政年份:2011
- 资助金额:
$ 39.01万 - 项目类别:
Control of Sterol and Lipoprotein Homeostasis by miRNA
miRNA 对甾醇和脂蛋白稳态的控制
- 批准号:
8644305 - 财政年份:2011
- 资助金额:
$ 39.01万 - 项目类别:
Control of Sterol and Lipoprotein Homeostasis by miRNA
miRNA 对甾醇和脂蛋白稳态的控制
- 批准号:
8444487 - 财政年份:2011
- 资助金额:
$ 39.01万 - 项目类别:
Control of Sterol and Lipoprotein Homeostasis by miRNA
miRNA 对甾醇和脂蛋白稳态的控制
- 批准号:
8816115 - 财政年份:2011
- 资助金额:
$ 39.01万 - 项目类别:
Control of Sterol and Lipoprotein Homeostasis by miRNA
miRNA 对甾醇和脂蛋白稳态的控制
- 批准号:
8087156 - 财政年份:2011
- 资助金额:
$ 39.01万 - 项目类别:
相似海外基金
The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
- 批准号:
EP/Z000920/1 - 财政年份:2025
- 资助金额:
$ 39.01万 - 项目类别:
Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
- 批准号:
FT230100276 - 财政年份:2024
- 资助金额:
$ 39.01万 - 项目类别:
ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
- 批准号:
MR/X024261/1 - 财政年份:2024
- 资助金额:
$ 39.01万 - 项目类别:
Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
- 批准号:
DE240100388 - 财政年份:2024
- 资助金额:
$ 39.01万 - 项目类别:
Discovery Early Career Researcher Award
Zootropolis: Multi-species archaeological, ecological and historical approaches to animals in Medieval urban Scotland
Zootropolis:苏格兰中世纪城市动物的多物种考古、生态和历史方法
- 批准号:
2889694 - 财政年份:2023
- 资助金额:
$ 39.01万 - 项目类别:
Studentship
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
- 批准号:
2842926 - 财政年份:2023
- 资助金额:
$ 39.01万 - 项目类别:
Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
- 批准号:
NC/X001644/1 - 财政年份:2023
- 资助金额:
$ 39.01万 - 项目类别:
Training Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
- 批准号:
2337595 - 财政年份:2023
- 资助金额:
$ 39.01万 - 项目类别:
Continuing Grant
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
- 批准号:
2232190 - 财政年份:2023
- 资助金额:
$ 39.01万 - 项目类别:
Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
- 批准号:
23K17514 - 财政年份:2023
- 资助金额:
$ 39.01万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)